Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1159 of 6351
-
Brain training with MRI shows promise for depression
Disease control Recruiting nowPrevious work demonstrated that individuals are able to self-regulate their ventral tegmental area (VTA) activity using real-time biofeedback. The current study expands this approach to a larger sample with repeated training sessions to more robustly characterize the effects of V…
Sponsor: University of Oxford • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could short bursts of intense exercise boost heart recovery better than steady workouts?
Disease control Not yet recruitingThis randomized controlled trial aims to compare the effects of High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) in patients undergoing Phase II cardiac rehabilitation after coronary artery disease or post-angioplasty. A total of 66 partic…
Sponsor: Riphah International University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
One scan to catch two silent threats: MRI may spot bone and muscle loss in kidney patients
Diagnosis Not yet recruitingThis is a single-center, observational cohort study aiming to validate the diagnostic value of MRI-FF in identifying osteoporosis and sarcopenia in patients with chronic kidney disease (CKD). A total of 868 participants, including 434 CKD patients and 434 non-CKD controls, will b…
Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Brain zapping without surgery: new device targets deep brain regions to treat depression and anxiety
Symptom relief Not yet recruitingThis multi-center, double-blind study, randomized controlled trial aims to evaluate the efficacy and safety of Temporal Interference transcranial Alternating Current Stimulation (TI-tACS) in patients with major depressive disorder (MDD) and generalized anxiety disorder (GAD). Al…
Sponsor: Central South University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Blood test may spot returning cervical cancer before symptoms appear
Knowledge-focused Not yet recruitingPrimary Objective of this study: To investigate the correlation between longitudinal quantitative dynamics of circulating tumor DNA (ctDNA) and HPV-derived cell-free DNA (HPV cfDNA) in peripheral blood and clinical prognosis among patients with recurrent and metastatic cervical c…
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
AI could spot hidden heart disease without extra needles
Diagnosis Not yet recruitingThe aim of this study is to establish the diagnostic performance of the AngioAI+ System (AngioInsight, Inc, USA) for estimating: 1. Fractional flow reserve (FFR) and 2. Detection of coronary microvascular disease (CMD) SMARTFLOW is a prospective, single-arm, observational multi…
Sponsor: AngioInsight • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
New drug duo aims to tackle rare leukemia
Disease control By invitation onlyinvestigators propose a phase II, open label-nonrandomized, single arm, multicenter study aiming to assess the safety and efficacy with the combination of Rituximab and Zanubrutinib in patients with HAIRY CELL LUKEMIA HCL, or HAIRY CELL LEUKEMIA VARIANT-HCLv.
Phase 2 • Sponsor: Bnai Zion Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Which biopsy route catches more aggressive prostate cancers?
Diagnosis Recruiting nowThis prospective randomized controlled trial aims to compare transperineal and transrectal cognitive fusion prostate biopsy techniques in patients with suspicious prostate lesions detected by multiparametric magnetic resonance imaging (mpMRI). Patients aged 50-75 years with PI-R…
Sponsor: Ankara Etlik City Hospital • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
Could a year of hormone pills before surgery spare lymph nodes in breast cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether letrozole, a hormone therapy drug, is effective in treating early-stage, hormone receptor-positive, HER2-negative breast cancer that has spread to nearby lymph nodes in postmenopausal women. The study will also evaluate the safe…
Phase 2 • Sponsor: Cancer Care Hospital & Research Centre Foundation, Lahore • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New pill aims to tame severe gut disease
Disease control Not yet recruitingThe purpose of this phase III, multicenter, double-blind, placebo-controlled study is to evaluate the efficacy and safety of Hemay005 compared to placebo as induction and maintenance therapy in Chinese participants with moderately to severely active ulcerative colitis.
Phase 3 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to restore skin color in vitiligo patients
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to assess the efficacy, safety, and tolerability of LW402 tablets in participants with non-segmental vitiligo. Drawing on the prior/preclinical data of LW402 tablets, this clinic…
Phase 2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New sleep aid HS-10506 enters final testing phase
Symptom relief Not yet recruitingThe primary purpose of this phase 3 study is to evaluate the safety and the efficacy of HS-10506 (change versus placebo) on latency to persistent sleep (LPS) and wakefulness after sleep onset (WASO) measured by polysomnography (PSG) in Chinese adult participants with insomnia dis…
Phase 3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Fetal balloon surgery aims to save babies with rare birth defect
Disease control Recruiting nowThis is a single site, single arm, non-randomized, pilot trial to assess the feasibility and safety of treating severe congenital diaphragmatic hernia (CDH) with Fetal Endoscopic Tracheal Occlusion (FETO) at Columbia University Irving Medical Center (CUIMC)/ NewYork-Presbyterian …
Sponsor: Vincent Duron • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy aims to control returning lung cancer in targeted patients
Disease control Recruiting nowThis study is designed as a multi-cohort trial based on various patient biomarkers study with the potential to include new study treatment in the future. EGFR-sensitive mutation-positive patients with distant recurrence after adjuvant osimertinib treatment for EGFRm resectable SI…
Phase 4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Pilot study tests safer blood thinner options for pregnant women with mechanical heart valves
Disease control Recruiting nowThe purpose of this pilot study is to collect data on pregnancies with mechanical heart valves to see if using a blood thinner called low molecular weight heparin (LMWH) and low dose aspirin (LDA) is comparable to warfarin/vitamin K antagonist (VKA) to reduce the chance of clotti…
Sponsor: Mount Sinai Hospital, Canada • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
AI reads skin lesions to predict cancer aggressiveness
Knowledge-focused Recruiting nowThis retrospective observational study aims to develop and evaluate a convolutional neural network (CNN)-based artificial intelligence model for risk classification and histopathological subtype prediction of basal cell carcinoma (BCC) using clinical and dermoscopic images. Histo…
Sponsor: Istanbul Training and Research Hospital • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to heal hearts after major attack
Disease control Not yet recruitingThe goal of this phase IIc clinical trial is to learn if recombinant human thymosin beta 4 injection (NL005) works to treat heart damage in people who have had a serious type of heart attack called ST-segment elevation myocardial infarction (STEMI) and have been treated with emer…
Phase 2 • Sponsor: Beijing Northland Biotech. Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a class tame pregnancy stress at the genetic level?
Knowledge-focused Recruiting nowThe aim of this study is to evaluate the effects of stress management and epigenetic awareness training provided in prenatal classes on maternal stress levels, cortisol levels, and epigenetic awareness. The main questions it aims to answer are: 1. Do stress management and epige…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Liver transplant kids test cutting meds in half
Disease control Recruiting nowThis is a prospective multi-center, longitudinal study to determine efficacy of 50 percent Immunosuppression (IS) reduction. One hundred fully eligible participants will reduce IS by 50 percent in two steps. Liver tests will be checked every 0.5 months through month 4, once a mon…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can an injection restore hearing? new trial tests DX243 in older adults
Disease control Recruiting nowPhase 2a: Multiple Ascending Dose (MAD) in male and female patients with hearing loss: The study will be conducted according to a randomised, placebo-controlled, double-blind design. A total of 24 patients, otherwise healthy, aged up to 75 years old, with mild to moderate hearin…
Phase 2 • Sponsor: Dendrogenix • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC